Mallinckrodt Pharmaceuticals announced plans to file for bankruptcy. The plan would allow the pain pill manufacturer to pay $1 billion less to a trust as part of a settlement of claims that it helped fuel the nation’s opioid crisis. (The Washington Post)
Johnson & Johnson’s Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an emailed response, J&J confirmed plans to exit some of its vaccine research and development programs, which it said it had initially disclosed in its 2023 second-quarter results. (Reuters)
The Food and Drug Administration issued a warning for hidden ingredients in products marketed as energy-enhancing with sexual enhancement benefits. The FDA is notifying consumers that certain products promoted for energy enhancement have been found to contain hidden ingredients and may pose a significant health risk. (WKBN)
AstraZeneca has two lawsuits ahead of it in London, including one from the husband of a woman who died after receiving the drugmaker’s COVID-19 vaccine. These could be the first of potentially dozens of cases brought in England. (Al Jazeera)
A commentary piece argued that former Roviant Sciences CEO Vivek Ramaswamy is a ‘tech bro’ and the latest madman to rattle the traditional Republican presidential field. “Ramaswamy is Ivy League educated but, like many self appointed populists, claims contempt for liberal elites,” Sarah Baxter wrote. (Evening Standard)
